Targeted therapeutics and novel signaling pathways in non-alcohol-associated fatty liver/steatohepatitis (NAFL/NASH)

por Xu, Xiaohan, Poulsen, Kyle L., Wu, Lijuan, Liu, Shan, Miyata, Tatsunori, Song, Qiaoling, Wei, Qingda, Zhao, Chenyang, Lin, Chunhua, Yang, Jinbo
Publicado 2022

Bioactive compound C498-0670 alleviates LPS-induced sepsis via JAK/STAT and NFκB signaling pathways

por Xu, Jing, Zhang, Xinxin, Zhou, Mingming, Lu, Peizhe, Xu, Yuting, Wu, Lihong, Zhang, Qianyue, Wu, Zhihua, Xu, Xiaoyu, Shi, Pengfei, Wei, Qingda, Li, Xiaoyu, Song, Qiaoling
Publicado 2023

Identification of Cytochrome P450 2E1 as a Novel Target in Glioma and Development of Its Inhibitor as an Anti‐Tumor Agent

por Hu, Guiming, Fang, Yan, Xu, Haiwei, Wang, Guanzhe, Yang, Rui, Gao, Fei, Wei, Qingda, Gu, Yuhan, Zhang, Cunzhen, Qiu, Jinhuan, Gao, Na, Wen, Qiang, Qiao, Hailing
Publicado 2023